IPP Bureau
Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints
By IPP Bureau - May 06, 2026
The proposed biosimilar to Keytruda demonstrated pharmacokinetic bioequivalence in a multicountry Phase 1 study involving non-small cell lung cancer patients
Ajanta Pharma Q4 FY26 revenue surges 21% to Rs 1,422 Crore; PAT climbs 18%
By IPP Bureau - May 06, 2026
FY26 revenue rises 17% to Rs 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter
Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal
By IPP Bureau - May 06, 2026
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
Laurus Labs Q4 profit rises to Rs 279 crore, FY26 revenue up 23%
By IPP Bureau - May 06, 2026
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility
By IPP Bureau - May 06, 2026
The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
OBESITAS 2026 concludes with focus on India’s rising obesity burden
By IPP Bureau - May 05, 2026
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
Govt, academia and industry collaboration crucial for scientific progress: Dr Jitendra Singh
By IPP Bureau - May 05, 2026
The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders
Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
By IPP Bureau - May 05, 2026
The private funding rose 38% amid growing international collaborations and CDMO demand
Novartis locks in $23 billion US expansion with seventh new facility
By IPP Bureau - May 05, 2026
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
Dr Odin launches ‘Odin Buddy’ kids’ nebulizer for child-friendly respiratory care
By IPP Bureau - May 05, 2026
New pediatric nebulizer combines playful design and engaging features to make breathing treatments less stressful for children and parents
OneSource powers second generic semaglutide nod in Canada
By IPP Bureau - May 05, 2026
Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs
Medanta appoints Dr Shalini Tyagi as Director, Paediatric Care at Noida unit
By IPP Bureau - May 05, 2026
Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.
KPMG report finds healthcare CEOs betting big on AI amid workforce and system pressures
By IPP Bureau - May 05, 2026
Report highlights growing confidence in digitalisation and AI, even as healthcare leaders remain concerned about workforce gaps, cybersecurity, and data readiness
Redcliffe Labs elevates Gaurav Jain as Chief Operating Officer
By IPP Bureau - May 05, 2026
Leadership transition strengthens Redcliffe Labs’ focus on scaling technology-led diagnostics, operational excellence, and preventive healthcare access
World Asthma Day: Apollo Spectra Hospital urges early diagnosis and treatment adherence
By IPP Bureau - May 05, 2026
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
